AOTI
NEUTRALAOTI, Inc. Announces Holding Change
The healthcare company has announced a change in shareholding, with Wasatch Advisors, LP now holding 13.677% of the voting rights.
AOTI, Inc.
65.00GBX
13.04%
Market Cap
69.13M
Volume
158.83k
66% of avg
P/E Ratio
EPS (TTM)
Beta
Day Range
57.50p - 65.00p
52 Week Range
50.00p65.00p135.00p
65.00p
Upcoming Events
AOTI
NEUTRALAOTI Inc. Announces Director Share Purchase
The CFO of the medical device company has increased their shareholding in the business.
AOTI
NEUTRALAOTI Secures Medicaid Provider ID in California
The medical device company has been granted a Medicaid Provider ID in California, the largest Medicaid state, allowing it to secure insurers and obtain coverage for its wound treatment therapy.
AOTI
BADAOTI Faces Headwinds in Q2 2025 but Remains Confident in Medium-Term Growth
The medical device company faces headwinds in Q2 2025, leading to a downgrade in full-year revenue and EBITDA guidance, as it navigates disruption in key segments and prepares for the impact of new government initiatives.
AOTI
NEUTRALAOTI expands access to German market for wound therapy
The medical device company has received a positive recommendation from Germany's healthcare regulator for national reimbursement coverage of its wound therapy, unlocking access to the large German market.
AOTI
NEUTRALAOTI, Inc. Announces End of Distribution Compliance Period
The medical technology group AOTI, Inc. announces the end of a distribution compliance period for its securities.
AOTI
NEUTRALAOTI Releases 2024 Annual Report and AGM Notice
The medical technology group has released its 2024 annual report and notice of annual general meeting.
AOTI
NEUTRALAOTI Presents at AJ Bell and Shares Spotlight Event
The medical technology group AOTI will present at an investor event in London, providing an overview of the company.
AOTI
NEUTRALAOTI Director Buys Shares
The CFO of the medical device company has purchased a number of shares.
AOTI
NEUTRALAOTI Director Increases Shareholding
The Non-executive Chairman of the medical device company has purchased additional shares.